<DOC>
	<DOCNO>NCT00882999</DOCNO>
	<brief_summary>To look ability LY2127399 reduce magnetic resonance imaging ( MRI ) lesions 12 , 16 , 20 , 24 week compare placebo .</brief_summary>
	<brief_title>A Study Patients With Relapsing Remitting Multiple Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis , Relapsing-Remitting</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>18 64 year age diagnose relapsingremitting multiple sclerosis ( RRMS ) , walk without aid rest least 200 meter ( approximately 1/10 mile ) . Women become pregnant must use birth control . Have live vaccination within 12 week randomization , intend live vaccination course study . Have recent surgery schedule surgery study . Are immunocompromised evidence active infection ( hepatitis , tuberculosis , human immunodeficiency virus [ HIV ] ) . Have certain drug study RRMS recently receive prescription drug treat RRMS . Have recent serious infection . Have serious uncontrolled illness RRMS . Have clinically significant blood test value . Have multiple severe drug allergy . Have contraindication magnetic resonance imaging ( MRI ; `` scanning '' ) claustrophobia ( fear enclose space ) manage .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Relapsing</keyword>
	<keyword>Remitting</keyword>
	<keyword>Multiple Sclerosis</keyword>
	<keyword>Multiple</keyword>
	<keyword>Sclerosis</keyword>
	<keyword>MS</keyword>
	<keyword>LY2127399</keyword>
</DOC>